POWERS JOHNNY D

Director Johnny D Powers buys 500,000 shares of Zomedica at $0.05 for $23.0K, raising stake 17.1% to 3.42M shares

Director Johnny D Powers purchased 500,000 shares at $0.05, increasing his holdings by 17.1% to 3,425,000 shares. The stock currently trades at $0.05, unchanged from the transaction price, though it trades 37.5% below its 52-week high of $0.08. Fundamentally, Zomedica remains deeply unprofitable with a $-63.8M net loss in its most recent full fiscal year against $6.5M quarterly revenue. Notably, across Powers' cross-ticker open-market history, his prior 18 buys have generated an average 90-day return of -7.2% with only a 25.00% win rate, suggesting a mixed track record of capital allocation timing decisions.

Director Johnny D Powers buys 500,000 shares at blended $0.07 for $33.6K as part of 7-insider cluster buy pattern at unprofitable ZOM.

Director Johnny D Powers executed 6 separate purchases totaling 500,000 shares (500.0K shares) for $33,650.00 ($33.6K) on 2025-03-17, increasing his holdings by 20.6% from 2,425,000 shares to 2,925,000 shares (2.92M shares). This transaction is part of a coordinated cluster pattern in which 7 other insiders also bought within the past 14 days. However, the company context remains challenging: latest quarterly revenue is $7.0M against a net loss of $6.7M, and Zomedica remains unprofitable on a full-year basis. The insider's track record at this ticker is instructive: 5 prior open-market buys at ZOM showed 0 of 5 instances of positive 90-day returns, with outcomes ranging from -0.2% to -18.0% over the 90-day window. The stock is currently -44.4% from its 52-week high and down -18.6% in the past 30 days, trading at $0.10 relative to the $0.06–$0.07 transaction prices.

Director Johnny D Powers bought 100,000 shares of ZOM at $0.12 on 2024-11-11; 3 other insiders also bought within 14 days, but his prior ZOM trades show weak timing (1 of 4 well-timed at 90 days).

Johnny D Powers, Director, purchased 100,000 shares at $0.12 on 2024-11-11, increasing his holdings to 2,425,000 shares. The transaction occurs within a cluster of 3 other insider buys in the prior 14 days, suggesting coordinated conviction at current price levels. However, his timing history at ZOM is mixed: of 5 prior trades at this ticker, only 1 of 4 completed transactions with measurable 90-day outcomes was well-timed. His cross-ticker track record shows an average 90-day return of -8.5% across 11 prior buys, with a 30.00% win rate. The company remains unprofitable (net income $-6,697,000.00 in the latest quarter) despite 33.0% annual revenue growth. The stock is down 36.4% from its 52-week high ($0.22) and currently trades at $0.14, only marginally above the purchase price of $0.12.

Director JOHNNY D POWERS buys 100,000 ZOM shares at $0.13; post-transaction holdings: 2,325,000 shares

Director JOHNNY D POWERS purchased 100,000 shares of Zomedica at $0.13 on 2024-08-28, increasing holdings by 4.5% to 2,325,000 shares. At $0.13, the stock is trading 40.9% below its 52-week high and down 13.3% over the prior 30 days. Examining his same-ticker history at ZOM reveals a split pattern: three prior buys showed negative 90-day returns (-11.2%, -15.6%, -17.9%), while two other buys achieved positive 90-day returns (+11.9%, +11.1%), with a 40% timing success rate overall at this ticker. The company remains unprofitable with a net loss of $23.9M in its most recent full fiscal year despite revenue growth of 33.0%, reflecting fundamental weakness beneath the surface. This purchase follows a pattern of mixed timing outcomes and occurs in a distressed price environment.